These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 8092817

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of fleroxacin in renal impairment.
    Weidekamm E.
    Am J Med; 1993 Mar 22; 94(3A):70S-74S. PubMed ID: 8452185
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Penetration of fleroxacin into breast milk and pharmacokinetics in lactating women.
    Dan M, Weidekamm E, Sagiv R, Portmann R, Zakut H.
    Antimicrob Agents Chemother; 1993 Feb 22; 37(2):293-6. PubMed ID: 8452360
    [Abstract] [Full Text] [Related]

  • 7. Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans.
    Weidekamm E, Portmann R, Suter K, Partos C, Dell D, Lücker PW.
    Antimicrob Agents Chemother; 1987 Dec 22; 31(12):1909-14. PubMed ID: 3125788
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fleroxacin clinical pharmacokinetics.
    Stuck AE, Kim DK, Frey FJ.
    Clin Pharmacokinet; 1992 Feb 22; 22(2):116-31. PubMed ID: 1551289
    [Abstract] [Full Text] [Related]

  • 11. Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in elderly patients.
    Taburet AM, Devillers A, Thomare P, Fillastre JP, Veyssier P, Singlas E.
    Clin Pharmacokinet; 1990 Jul 22; 19(1):80-8. PubMed ID: 2116257
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics and tissue penetration of fleroxacin after single and multiple 400- and 800-mg-dosage regimens.
    Panneton AC, Bergeron MG, LeBel M.
    Antimicrob Agents Chemother; 1988 Oct 22; 32(10):1515-20. PubMed ID: 3142338
    [Abstract] [Full Text] [Related]

  • 13. Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in renal failure and influence of haemodialysis.
    Singlas E, Leroy A, Sultan E, Godin M, Moulin B, Taburet AM, Dhib M, Fillastre JP.
    Clin Pharmacokinet; 1990 Jul 22; 19(1):67-79. PubMed ID: 2116256
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Influence of sex on the pharmacokinetic interaction of fleroxacin and ciprofloxacin with caffeine.
    Kim MK, Nightingale C, Nicolau D.
    Clin Pharmacokinet; 2003 Jul 22; 42(11):985-96. PubMed ID: 12908854
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and biliary concentrations of fleroxacin in cholecystectomized patients.
    Hayton WL, Vlahov V, Bacracheva N, Viachki I, Portmann R, Muirhead G, Stoeckel K, Weidekamm E.
    Antimicrob Agents Chemother; 1990 Dec 22; 34(12):2375-80. PubMed ID: 2128442
    [Abstract] [Full Text] [Related]

  • 18. Effect of a fat- and calcium-rich breakfast on pharmacokinetics of fleroxacin administered in single and multiple doses.
    Bertino JS, Nafziger AN, Wong M, Stragand L, Puleo C.
    Antimicrob Agents Chemother; 1994 Mar 22; 38(3):499-503. PubMed ID: 8203844
    [Abstract] [Full Text] [Related]

  • 19. Penetration of fleroxacin into human and animal tissues.
    Portmann R, Weidekamm E.
    Chemotherapy; 1992 Mar 22; 38(3):145-9. PubMed ID: 1511632
    [Abstract] [Full Text] [Related]

  • 20. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E, Cloyd J, Critchley D, Fuseau E.
    Epilepsia; 2008 Jul 22; 49(7):1123-41. PubMed ID: 18503564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.